Filter
1317
Text search:
adverse
drug
event
Featured
169
338
Language
Document type
772
243
150
75
36
17
12
6
3
1
1
1
Countries / Regions
87
41
38
31
29
27
24
21
18
18
18
17
17
14
14
12
12
11
11
11
9
9
9
9
8
8
8
7
6
6
5
5
5
4
4
4
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
408
225
88
71
33
24
23
1
Toolboxes
139
135
130
72
65
45
40
38
30
30
23
18
16
15
14
12
10
8
7
6
4
2
1
Coordinated Use of Anthelminthic Drugs in Control Interventions: a Manual for Health Professionals and Programme Managers
Patient Safety tutorial 325
Antimicrobial resistance (AMR) has emerged as a major public health problem all over the world. Infections caused by resistant microbes fail to respond to treatment, resulting in prolonged illness and greater risk of death. This document focuses on the mechanism to develop a practically applicable h
...
Report of the 23rd WHO Expert Committee on the selection and use of essential medicines
This executive summary reports the recommendations made by the Expert Committee for the 2021 update of the WHO Model List of Essential Medicines (EML) and the Model List of Essential Medicine for Children (EMLc)
...
In 2018 and early 2019, the WHO Regional Office for Europe’s cultural contexts of health and well-being project worked alongside the University of Exeter’s WHO Collaborating Centre on Culture and Health, the Minsk Regional Centre for Psychiatry and Addiction, and the Institute of Mental Health o
...
Interim policy guidance
Recommendations for a public health approach
2010 revision
Document No. : FDA/SMC/CTD/GL-CCT/2013/01
MMWR: Recommendations and Reports / Vol. 62 / No. 9
Morbidity and Mortality Weekly Report
October 25, 2013
(updated December 2014).
